Home
/ UroMems
/ Competitors

UroMems Competitors and Similar CompaniesClear all

UroMems's competitors and similar companies include Obalon Therapeutics, Novian Health, E-Qure and AdaptHealth.

	UroMems UroMems is focuses on designing, developing and commercializing active implantable medical devices.	Obalon Therapeutics Obalon Therapeutics offers gastric balloon technology that assists weight loss by inducing a feeling of fullness.	Novian Health Novian Health is a medical device company employing its proprietary interstitial laser therapy for the treatment of breast tumors.	E-Qure E-QURE developed a non-invasive, electrical stimulation (ES), medical device that cures Hard-to-Heal wounds and Ulcers.	AdaptHealth AdaptHealth a full-service home medical equipment and respiratory company offering a breadth of clinically-focused products and services.
Founding Date	Founding Date 2011	Founding Date 2008	Founding Date 1991	Founding Date 2014	Founding Date 2012
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy
Locations	Locations Grenoble, FR HQ	Locations Carlsbad, US HQ	Locations Chicago, US HQ évry Courcouronnes, FR Chicago, US Tonganoxie, US	Locations New York, US HQ	Locations Conshohocken, US HQ Phoenixville, US
Employees	Employees N/A	Employees 294% decrease	Employees 9	Employees 1	Employees 2,6011% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 30.6 m	Valuation ($) N/A	Valuation ($) 6.9 k	Valuation ($) 1.5 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $319.7k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $3.2b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $100.9k (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $2.6b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $218.8k (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $609.2m (FY, 2025)
Net income	Net income N/A	Net income ($10.5m) (FY, 2025)	Net income N/A	Net income ($612.4k) (FY, 2020)	Net income ($66m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 17.5m (about 6 years ago)	Latest funding round N/A	Latest funding round $ 1m (over 11 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 32.6m	Total funding raised $ 20m	Total funding raised $ 24.7m	Total funding raised N/A	Total funding raised N/A